DocGo Inc. (NASDAQ:DCGO) Given Average Rating of “Buy” by Brokerages

Shares of DocGo Inc. (NASDAQ:DCGO) have been assigned a consensus recommendation of “Buy” from the five research firms that are currently covering the company, MarketBeat reports. Five investment analysts have rated the stock with a buy recommendation. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $7.75.

A number of research firms have recently commented on DCGO. BTIG Research reduced their price objective on shares of DocGo from $11.00 to $7.00 and set a “buy” rating for the company in a report on Thursday, May 9th. Stifel Nicolaus reduced their price objective on shares of DocGo from $8.00 to $6.50 and set a “buy” rating for the company in a report on Tuesday, April 30th. Canaccord Genuity Group cut their price target on shares of DocGo from $9.00 to $5.00 and set a “buy” rating for the company in a report on Thursday, May 9th. Cantor Fitzgerald cut their price target on shares of DocGo from $11.00 to $5.00 and set an “overweight” rating for the company in a report on Thursday, May 9th. Finally, Needham & Company LLC cut their price target on shares of DocGo from $10.00 to $7.00 and set a “buy” rating for the company in a report on Thursday, May 9th.

DocGo Stock Performance

NASDAQ:DCGO opened at $2.99 on Wednesday. The company has a 50-day moving average of $3.17 and a 200-day moving average of $3.66. The company has a market capitalization of $303.69 million, a price-to-earnings ratio of 14.95, a PEG ratio of 1.54 and a beta of 0.91. DocGo has a 52 week low of $2.78 and a 52 week high of $10.82.

DocGo (NASDAQ:DCGO) last released its quarterly earnings data on Wednesday, May 8th. The company reported $0.09 EPS for the quarter, hitting analysts’ consensus estimates of $0.09. The company had revenue of $192.09 million during the quarter, compared to the consensus estimate of $185.36 million. DocGo had a net margin of 2.98% and a return on equity of 6.20%. Sell-side analysts forecast that DocGo will post 0.24 EPS for the current year.

Insider Transactions at DocGo

In other DocGo news, General Counsel Ely D. Tendler purchased 10,000 shares of the stock in a transaction dated Monday, May 13th. The stock was bought at an average price of $3.13 per share, for a total transaction of $31,300.00. Following the transaction, the general counsel now directly owns 162,933 shares in the company, valued at $509,980.29. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other DocGo news, General Counsel Ely D. Tendler purchased 10,000 shares of the stock in a transaction dated Monday, May 13th. The stock was bought at an average price of $3.13 per share, for a total transaction of $31,300.00. Following the transaction, the general counsel now directly owns 162,933 shares in the company, valued at $509,980.29. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Lee Bienstock purchased 25,000 shares of the stock in a transaction dated Monday, May 13th. The shares were acquired at an average price of $3.15 per share, with a total value of $78,750.00. Following the transaction, the chief executive officer now owns 1,220,845 shares in the company, valued at $3,845,661.75. The disclosure for this purchase can be found here. 2.70% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. AJOVista LLC acquired a new position in DocGo during the fourth quarter valued at approximately $25,000. Cape Investment Advisory Inc. acquired a new position in DocGo during the fourth quarter valued at approximately $63,000. Verdence Capital Advisors LLC acquired a new position in DocGo during the first quarter valued at approximately $64,000. Worth Venture Partners LLC grew its holdings in DocGo by 36.3% during the third quarter. Worth Venture Partners LLC now owns 16,028 shares of the company’s stock valued at $85,000 after purchasing an additional 4,265 shares during the period. Finally, Intrust Bank NA acquired a new position in DocGo during the fourth quarter valued at approximately $85,000. Institutional investors and hedge funds own 56.44% of the company’s stock.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.